2025 ISAKOS Congress in Munich, Germany

ISAKOS 2025 Congress Faculty

 

Norimasa Nakamura, MD, PhD

Osaka Health Science University
Osaka, Osaka JAPAN

Norimasa Nakamura is professor of the Institute for Medical Science in Sports at Osaka Health Science University and the center for the advanced medical engineering and informatics at Osaka University. He is an orthopedic surgeon at the Osaka University Hospital, Osaka, Japan, specializing in arthroscopic surgery. He received his MD at the Osaka University in 1988 and completed a specialization in orthopedics in 1992. In 1994, he received a PhD. In 1995, he became Assistant Professor of orthopedics at the Osaka University and in 2009, moved to the current position. His research has been focused on joint tissue repair specifically in the regeneration of cartilage, ligament, and meniscus with stem cells. Today the main interest is the joint preservation surgery, biotherapies to osteoarthritis, and the clinical application of three-dimensional osteochondral bio-implant using stem cells. He served as the president of the International Cartilage Regeneration and Joint Preservation Society (ICRS) 2016-2018). Also, he served as the chair of the Scientific Committee (2013-2015), the Publication Committee (2019-2021)。He is currently the member of Executive Committee (Consultant 2021-) of ISAKOS.

Sun 06/08
10:00 - 11:30
Room 13b - MTE Meet the Experts: Biologics
Meet the Expert
Stem Cells, Growth Factors, Adipose Tissue and BMAC: Instructions for Use
Chair
Tue 06/10
14:50 - 14:55
Room 14c Afternoon Scientific Session I
Paper
Phase III Clinical Trial For Knee Chondral Lesions Repair Using Scaffold-Free, Impurity-Free Tissue-Engineered Construct Generated From Allogenic Synovial Mesenchymal Stem Cells (Golmestrocel)
Author
Tue 06/10
15:45 - 17:00
General Session - Auditorium Afternoon Scientific Session II
Global Case-based Discussion Session
Meniscus Repair in 2025: Can We Improve the Healing?
Co-Chair
ePosters
Knee - Cartilage
E-Poster
Correlation Between MRI And Histological Analyses For Repair Tissue Of Knee Chondral Lesions Treated With Allogenic Mesenchymal Stem Cell-Based Therapy Or Microfracture In A Phase III Clinical Trial Cohort
Author

Disclosures

Paid Consultant for Cell Source
Support received from Cell Source, Two Cells Ltd.
Editorial or Governing board of American Journal of Sports Medicine, Journal of Experimental Orthopardics (Springer), Journal of ISAKOS, Journal of Orthopaedic Science (Springer), Sage (Cartilage)
Board of Directors member for International Cartilage Repair Society, International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine

All relevant financial disclosures have been mitigated.